Antiglio

Epitopoietic research, anti-cancer fund. This Token is created with the sole purpose of gathering funds that will be used for medical research for the treatment of glioblastoma patients. Funds gathered will be transferred to start-up pharma laboratories and pharma companies that have active research programs against glioblatoma. Companies will pledge shares against funds that will be granded to them. The ecosystem and the price of the token will be backed by these stocks securing the price of the token.

Withdrawn:

0.0000

Holders:

Already released:

8 269 823.0593

Not yet released:

1 730 176.9406

Active orders:

1 500 000.0000

Created on:

27 Jan 2022

Active orders:

1 500 000.0000

Release period:

5 year(s)

Hourly installment:

106.7351

Already released:

8 269 823.0593

Holders:

Wallet on exchange:

6 769 823.0593

Withdrawn:

0.0000

Sold on the market:

0.0000

Not yet released:

1 730 176.9406

Direct buy volume: